Crystal structure of toceranib, C22H25FN4O2
Journal Article
·
· Powder Diffraction
- Illinois Institute of Technology, Chicago, IL (United States); North Central College, Naperville, IL (United States)
- ICDD, Newtown Square, PA (United States)
The crystal structure of toceranib has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Toceranib crystallizes in space group P21/c (#14) with a = 10.6899(6), b = 24.5134(4), c = 7.8747(4) Å, β = 107.7737(13)°, V = 1965.04(3) Å3, and Z = 4. The crystal structure consists of stacks of approximately planar molecules, with N–H∙∙∙O hydrogen bonds between the layers. The commercial reagent sample was a mixture of two or more phases with toceranib being the dominant phase. The difference between the Rietveld-refined and DFT-optimized structures is larger than usual. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®).
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423351
- Journal Information:
- Powder Diffraction, Journal Name: Powder Diffraction Journal Issue: 1 Vol. 38; ISSN 0885-7156
- Publisher:
- Cambridge University PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crystal structure of nequinate, C22 H23 NO4
Crystal structure of ponazuril, C18H14F3N3O6S
Crystal structure of oxfendazole, C15H13N3O3S
Journal Article
·
Sun Sep 18 20:00:00 EDT 2022
· Powder Diffraction
·
OSTI ID:2423347
Crystal structure of ponazuril, C18H14F3N3O6S
Journal Article
·
Sun Oct 02 20:00:00 EDT 2022
· Powder Diffraction
·
OSTI ID:2423350
Crystal structure of oxfendazole, C15H13N3O3S
Journal Article
·
Thu Jan 26 19:00:00 EST 2023
· Powder Diffraction
·
OSTI ID:2423348